Purpose/Objective: Relevant dosimetric errors, which can be identified using sub-arc analyses, may be obscured when performing integral dose QA for VMAT. Sub-arc EPID-based pre-treatment dose verification requires synchronization of the acquired images to Control Points (CPs). Published methods use logging features provided by the linac vendor or specific hardware solutions. This work aimed to develop an independent software-based synchronization method relying exclusively on information from the acquired images. Moreover, the sensitivity of this novel QA method to detect clinically relevant errors in leaf positioning and dose rate was assessed, both for sub-arc and integral dose QA. Materials and Methods: During VMAT delivery, raw EPID images are continuously acquired. The images are converted to Portal Dose Images (PDI) after correction for EPID induced effects like crosstalk. In contrast to other methods, synchronization of images to CPs of the VMAT sequence is based on the near maximum grey value in each image. The ratio between this value and the sum of all near maxima is proportional to the number of MU delivered during acquisition of that image. From the CPs, both the integral VMAT fluence and fluences corresponding to 10 ME sub-arcs can be derived, taking into account the dynamic behaviour of the plan. The method was tested using a cooled CCD-camera based EPID at six Elekta linacs for a group of 15 prostate cancer patients. PDI predictions were compared to the measurements using a gamma evaluation with 2%/2mm reference values for integral dose QA and 3%/3mm for subarc analyses. To assess the methods sensitivity, systematic and temporal perturbations in MLC positioning and dose delivery were introduced in a nominal plan. Results: For the 15 patients, on average 99.6 ± 0.3% (1 SD) of pixels passed the gamma test for integral VMAT QA. The average mean gamma was 0.30 ± 0.02. Also sub-arc analyses showed good results with overall mean pass rates of 98.6 ± 0.9% and median mean gamma values of 0.25 ± 0.02 (see Figure 1 ). In time and between different linacs the QA results were highly reproducible. By evaluating integral PDIs, errors in MLC leaf positioning, reducing the distance between opposing leaves by 1 mm, resulting in a 2.4% change in mean prostate dose, could easily be detected. Using sub-arc analyses, temporal perturbations, like a stuck leaf for 5 CPs resulted in a large increase in near maximum gamma values (γ 1 ). Temporal dose perturbations, like an addition or reduction of 1 MU per CP over a range of 10 CPs, while maintaining the overall number of MUs constant, were also clearly detectable. Conclusions: A novel method to synchronize acquired EPID images to VMAT delivery was developed, allowing accurate sub-arc VMAT dose verification. Without major adaptations it can also be used in other clinics. Even small deviations to nominal treatment plans could easily be detected. Currently, we apply this method routinely for VMAT QA.
Purpose/Objective: Relevant dosimetric errors, which can be identified using sub-arc analyses, may be obscured when performing integral dose QA for VMAT. Sub-arc EPID-based pre-treatment dose verification requires synchronization of the acquired images to Control Points (CPs). Published methods use logging features provided by the linac vendor or specific hardware solutions. This work aimed to develop an independent software-based synchronization method relying exclusively on information from the acquired images. Moreover, the sensitivity of this novel QA method to detect clinically relevant errors in leaf positioning and dose rate was assessed, both for sub-arc and integral dose QA. Materials and Methods: During VMAT delivery, raw EPID images are continuously acquired. The images are converted to Portal Dose Images (PDI) after correction for EPID induced effects like crosstalk. In contrast to other methods, synchronization of images to CPs of the VMAT sequence is based on the near maximum grey value in each image. The ratio between this value and the sum of all near maxima is proportional to the number of MU delivered during acquisition of that image. From the CPs, both the integral VMAT fluence and fluences corresponding to 10 ME sub-arcs can be derived, taking into account the dynamic behaviour of the plan. The method was tested using a cooled CCD-camera based EPID at six Elekta linacs for a group of 15 prostate cancer patients. PDI predictions were compared to the measurements using a gamma evaluation with 2%/2mm reference values for integral dose QA and 3%/3mm for subarc analyses. To assess the methods sensitivity, systematic and temporal perturbations in MLC positioning and dose delivery were introduced in a nominal plan. Results: For the 15 patients, on average 99.6 ± 0.3% (1 SD) of pixels passed the gamma test for integral VMAT QA. The average mean gamma was 0.30 ± 0.02. Also sub-arc analyses showed good results with overall mean pass rates of 98.6 ± 0.9% and median mean gamma values of 0.25 ± 0.02 (see Figure 1 ). In time and between different linacs the QA results were highly reproducible. By evaluating integral PDIs, errors in MLC leaf positioning, reducing the distance between opposing leaves by 1 mm, resulting in a 2.4% change in mean prostate dose, could easily be detected. Using sub-arc analyses, temporal perturbations, like a stuck leaf for 5 CPs resulted in a large increase in near maximum gamma values (γ 1 ). Temporal dose perturbations, like an addition or reduction of 1 MU per CP over a range of 10 CPs, while maintaining the overall number of MUs constant, were also clearly detectable. Conclusions: A novel method to synchronize acquired EPID images to VMAT delivery was developed, allowing accurate sub-arc VMAT dose verification. Without major adaptations it can also be used in other clinics. Even small deviations to nominal treatment plans could easily be detected. Currently, we apply this method routinely for VMAT QA. Purpose/Objective: The purpose of this study is to develop statistically based action levels for error detection during real-time EPID-based patient treatment verification for IMRT and VMAT based on measured real-time patient verification results. Materials and Methods: The real-time verification system (Watchdog) utilises a comprehensive physics-based model to generate a series of predicted transit cine EPID image as a reference data set, and compares these to measured cine-EPID images acquired during treatment. The agreement between the predicted and measured transit images is quantified using chi-comparison (currently 4%,4 mm) on a cumulative frame basis. Cine-EPID images were acquired from the first two fractions of 37 IMRT patients to generate the action levels; 10 Prostate treatments, 10 head and neck treatments, 7 Pelvic treatments, and 10 rectum treatments. Statistical process control (SPC) was used to generate the action levels at 3 standard deviations from the mean for each treatment site. The action level function is separated into two phases; 0-2 seconds, and >2 seconds to account for uncertainty at the beginning of image acquisition. Results: In the first 2 seconds of treatment, a linear action function was defined (see figure) . The derived action levels (4%,4 mm) after 2 seconds of image acquisition for prostate, H&N, pelvic, and rectum were 67%, 50%, 63%, and 61% respectively. In the figure, an error detected toward the end of the treatment course for a head and neck patient correlated with weight loss shown on CBCT scans.
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Conclusions:
We have developed preliminary action levels for a real-time EPID based treatment verification system (Watchdog). These action levels are designed to be applied to real-time verification during treatment with immediate intervention during SBRT treatments and post-delivery investigation during standard fractionation. Initial results found that the system detected significant changes in patient contour due to weight loss for a head and neck treatment.
Purpose/Objective: Film dosimetry with Gafchromic EBT3 represents a widespread tool to assess dose distributions in conventional Radiotherapy. Their use becomes more difficult in RadioSurgery and Hypofractionated Radiotherapy, where high doses per fraction are delivered and film sensitivity is limited. Aim of this work is to propose and validate a novel and comprehensive dosimetric approach, implementing the innovative Sum Signal (SS) method to increase film sensitivity and effectively extend EBT3 use also to high dose patient specific Quality Assurance (QA).
Materials and Methods:
To characterize film dose response, 3x3cm 2 films were irradiated with a 6MV photon beam (range: 0-24Gy), contextually measuring delivered doses with an ionization chamber. Films were digitized to obtain net optical densities (netOD) for Red Channel (RC) and Green Channel (GC). The SS was calculated by linearly summing the netOD values obtained for RC and GC.
Calibration data were fitted using the effective variance method, which takes into account the uncertainties of net OD (σ y,i ) and of dose values (σ x,i ) by performing a fit with weights w i based on the effective uncertainties σ y,i,eff
The best fitting function was selected according to the Akaike Information Criterion (AIC), which ensures the best compromise between goodness of fit and number of fit parameter used. According to this criterion, the best fit function is the one showing the lowest AICc value:
where k is the number of parameters in the fit function, χ 2 is the reduced chi-square value and the last one is a correction term for finite samples. An homemade Matlab software was contextually developed to compare, in terms of gamma analysis, dose distributions delivered by a Cyberknife system on EBT3 films to those calculated by the treatment planning system. The new SS method and the conventional Single Channel (SC) one (consisting in using the RC for doses <10Gy and the GC for higher doses) were implemented in this software and compared calculating the % of γ points <1 for 20 patient plans with maximum planned dose range 6-21 Gy. The statistical relevance of the differences between the two methods was evaluated by the Wilcoxon signed-rank test. Results: Our analysis shows that the SS dose-response curve is characterized by a steeper trend in comparison with SC ones, providing higher dose accuracy in a broader dose range.
Best-fit analysis by AICc value shows that the double exponential function is able to fit the whole film dose response object of this study. The impact of the increase in sensitivity using SS was confirmed by the Gamma analysis, which shows that the % of γ points satisfying agreement criteria is significantly higher for the SS method with respect to the SC approach both for 3%-1mm and 4%-1mm acceptance criteria:
Conclusions:
The results demonstrate that the developed protocol implementing SS can be considered a novel and promising actor, able to improve dosimetric accuracy for high dose patient specific QA.
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Implementation and validation of an analytical model for prompt gamma imaging in scanned beam proton therapy E. Sterpin 1 , G. Janssens 2 , J. Smeets 2 , F. Vander Stappen 2 , D. Prieels 2 , S. Vynckier 3 1 Université Catholique de Louvain, Molecular Imaging Radiotherapy and Oncology, Brussels, Belgium 2 Ion Beam Applications, R&D, Louvain-la-Neuve, Belgium 3 Université Catholique de Louvain, Radiotherapy, Brussels, Belgium Purpose/Objective: Proton therapy is sensitive to range uncertainties. These uncertainties can be reduced by on-line in vivo monitoring of the range, which is possible by imaging the prompt gammas (PG) emitted by the protons. A recently developed PG camera prototype showed a 1-2 mm accuracy to detect range shifts at clinical beam currents. The range shift is determined by comparing a reference signal computed in patient geometry to a measured one. The reference signal should be ideally computed for all scanned spots for further selection of the most adequate probe spots to verify the range when the patient is on couch. Because of the huge number of spots (> 1000, typically), we implemented an analytical model much faster than lengthy Monte Carlo simulations (MC).
Materials and Methods:
The geometrical details of the camera are shown in the figure (part (a) ). The analytical model computes the PG detection signal by 1) compositionweighted addition of MC PG emission profiles previously generated in either 12 C, 14 N, 16 O, 31 P or 40 Ca; and 2) convolution of the emission signal by a transfer function of the camera. For the generation of reference PG emission
